| Literature DB >> 27921415 |
Esmaeil Mortaz1, Fatemeh Rezayat2, Davar Amani2, Arda Kiani3, Johan Garssen4, Ian M Adcock5, Aliakbar Velayati6.
Abstract
Sarcoidosis is a systemic granulomatous disorder of unidentified etiology, with a heterogeneous clinical presentation. It is characterized by a reduced delayed-type hypersensitivity to tuberculin and common antigens. The balance between Th1, Th17 and Regulatory T(Treg) cells controls T-cell proliferation and activation.The Th17/Treg ratio in the peripheral blood and bronchoalveolar lavage fluidis increased in patients with active sarcoidosis. Amplified IL-17A expression in granulomas and the presence of IL-17A+, IL-17A+IL-4+ and IL-17A+IFN-γ+ memory T helper cells in the circulation and BAL indicate Th17 cell involvement in granuloma induction and/or maintenance in sarcoidosis. Sarcoidosis should therefore be considered as a Th1/Th17 multisystem disorder and anti-IL-17/Th17 approaches that control and reduce IL-17Amay be an option, therefore, for the treatment of sarcoidosis.Here we provide a short overview as to the role of Th17 cells as critical cells in the pathogenesis of sarcoidosis.Entities:
Keywords: Granuloma; Interleukin 17; Sarcoidosis; Th17 cell
Mesh:
Substances:
Year: 2016 PMID: 27921415
Source DB: PubMed Journal: Iran J Allergy Asthma Immunol ISSN: 1735-1502 Impact factor: 1.464